Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Impact of Serum-derived Bovine Immunoglobulin/Protein Isolate (SBI) on Clostridium Difficile (C. Difficile) Infection (CDI) in Hospitalized Ulcerative Colitis (UC) Patients
Conditions
Interventions
Serum-derived bovine immunoglobulin/protein isolate (SBI)
Placebo
Locations
3
United States
University of Miami
Miami, Florida, United States
Northwestern University
Chicago, Illinois, United States
Rush University
Chicago, Illinois, United States
Start Date
December 1, 2015
Primary Completion Date
December 12, 2017
Completion Date
January 5, 2018
Last Updated
November 18, 2021
NCT06237452
NCT06071312
NCT03325855
NCT06839209
NCT04014413
NCT02636517
Lead Sponsor
Northwestern University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions